Science 37 and Xperiome in Rare Disease Studies


Science 37 announced a partnership with Xperiome, a global, rare disease health tech company. The partnership furthers Science 37's capabilities to bring research to patients enabling treating physicians the opportunity to advance research as an investigator. Science 37 will leverage Xperiome's insights from Raremark, including a specialized matching engine to connect research-ready members to clinical and real-world study opportunities.

For more information, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.